Connect with Intent – Ampel BioSolutions

Sep 20, 2021 | News, Lupus, Lupus 2022, Products

A while back we spoke with Amrie Grammer, President of Ampel BioSolutions about their precision medicine solutions for Lupus patients and their care teams. We’re excited to bring her back alongside Angel Derricott, Lupus advocate, to speak on their progress. Ampel recently announced a “breakthrough in precision and personalized medicine that could modernize the way doctors treat patients” across different disease states.

With the combined use of genomics and Machine learning, we will be able to guide clinical decision support and predict drug options for a variety of diseases including (but not limited to) lupus, psoriasis, scleroderma and dermatitis. We’ll discuss how options such as these can impact not only patient care and quality of life; but how a solution like this can help improve our current healthcare system, rebuild the patient/physician relationship, assist in clinical trials and mitigate long term cost/effect.

Pin It on Pinterest